Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey J Winham

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|June 15, 2016
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumRikki A Cannioto, Michael J LaMonte, Linda E Kelemen, et al.
Journal of Medical Genetics|June 18, 2020
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancerHonglin Song, Ed M Dicks, Jonathan Tyrer, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Cancer Medicine|April 3, 2018
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analysesJodie N Painter, Tracy A O'Mara, Andrew P Morris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|June 15, 2016
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumRikki A Cannioto, Michael J LaMonte, Linda E Kelemen, et al.
Journal of Medical Genetics|June 18, 2020
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancerHonglin Song, Ed M Dicks, Jonathan Tyrer, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Cancer Medicine|April 3, 2018
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analysesJodie N Painter, Tracy A O'Mara, Andrew P Morris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Pageof 21